358 (Metoprolol ER 200 mg)
Pill imprint 358 has been identified as Metoprolol succinate extended-release 200 mg.
Metoprolol is used in the treatment of atrial fibrillation; high blood pressure; supraventricular tachycardia; heart attack; angina (and more), and belongs to the drug class cardioselective beta blockers. Risk cannot be ruled out during pregnancy. Metoprolol 200 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- 358
- Strength:
- 200 mg
- Color:
- White
- Size:
- 9.00 mm
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Cardioselective beta blockers
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Ethex Corporation
- National Drug Code (NDC):
- 58177-0358
- Inactive Ingredients:
- calcium stearate
carboxymethylcellulose sodium
carnauba wax
croscarmellose sodium
glyceryl behenate
hypromellose
maltodextrin
methacrylic acid - methyl methacrylate copolymer (1:1)
microcrystalline cellulose
polydextrose
polyethylene glycol
povidone
sodium stearyl fumarate
titanium dioxide
triacetin
triethyl citrate
More about metoprolol
Consumer resources
- Metoprolol
- Metoprolol succinate extended-release tablets
- Metoprolol (Advanced Reading)
- Metoprolol Intravenous (Advanced Reading)
- Other brands: Metoprolol Tartrate, Metoprolol Succinate ER, Toprol-XL, Lopressor
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
